Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Menu
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Nutraceuticals
Psychedelics
Disclosures
Featured news in
The Life Sciences Report
Athersys Inc.
()
Athersys Announces Financial Results for Fourth Quarter and Full Year 2018 (3/14/2019)
view
ProMIS Neurosciences Inc.
(PMN:TSX; PMN:NCM)
ProMIS Neurosciences Announces Fiscal Year 2018 Annual Results (3/15/2019)
view
Caladrius Biosciences Inc.
(CLBS:NASDAQ)
Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results (3/14/2019)
view
Caladrius Biosciences Inc.
(CLBS:NASDAQ)
Caladrius Biosciences announces Purchase Agreement with Lincoln Park Capital for up to $26 million (3/14/2019)
view
Celgene Corp.
(CELG:NASDAQ)
Puma Biotech (PBYI) Up More Than 95% in 3 Months: Here's Why (3/14/2019)
view
Celgene Corp.
(CELG:NASDAQ)
Agenus Wins $7.5M Milestone Payment From Gilead, Stock Up (3/14/2019)
view
Caladrius Biosciences Inc.
(CLBS:NASDAQ)
Caladrius Biosciences to Host 2018 Fourth Quarter and Year End Financial Results Conference Call on Thursday, March 14, 2019 at 4:30 p.m. Eastern Time (3/13/2019)
view
Celgene Corp.
(CELG:NASDAQ)
Aerie (AERI) Receives FDA Nod for Rocklatan to Treat Glaucoma (3/13/2019)
view
Celgene Corp.
(CELG:NASDAQ)
Top Ranked Value Stocks to Buy for March 14th (3/14/2019)
view
Celgene Corp.
(CELG:NASDAQ)
Biotech Stock Roundup: REGN Gets FDA Nod for Dupixent & Other Pipeline News (3/13/2019)
view
Celgene Corp.
(CELG:NASDAQ)
Advancing Clinical Trials For Leukemia Patients Is Helping Improve Survival Rate (3/14/2019)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm Announces First Patient Enrolled in Phase 2 Clinical Trial of Progressive MS (3/14/2019)
view
Celgene Corp.
(CELG:NASDAQ)
Zacks.com featured expert Kevin Matras highlights: Sallie Mae, United Continental, Celgene and Ligand Pharmaceuticals (3/13/2019)
view
Celgene Corp.
(CELG:NASDAQ)
Regeneron/Sanofi's Dupixent Gets FDA Nod for Label Expansion (3/12/2019)
view
Celgene Corp.
(CELG:NASDAQ)
CELG vs. VRTX: Which Stock Is the Better Value Option? (3/13/2019)
view
Mesoblast Ltd.
(MESO:NASDAQ; MSB:ASX)
Mesoblast Features at Upcoming U.S. Investor Conferences (3/13/2019)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
VIDEO: BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) (3/13/2019)
view